Burning Rock Biotech (BNR) Total Liabilities (2019 - 2025)
Burning Rock Biotech has reported Total Liabilities over the past 7 years, most recently at $40.2 million for Q4 2025.
- For Q4 2025, Total Liabilities fell 5.17% year-over-year to $40.2 million; the TTM value through Dec 2025 reached $40.2 million, down 5.17%, while the annual FY2025 figure was $40.8 million, 2.26% down from the prior year.
- Total Liabilities for Q4 2025 was $40.2 million at Burning Rock Biotech, up from $36.9 million in the prior quarter.
- Over five years, Total Liabilities peaked at $71.5 million in Q1 2022 and troughed at $36.4 million in Q2 2025.
- A 5-year average of $50.1 million and a median of $49.0 million in 2023 define the central range for Total Liabilities.
- Biggest five-year swings in Total Liabilities: surged 85.57% in 2021 and later crashed 37.48% in 2023.
- Year by year, Total Liabilities stood at $67.8 million in 2021, then fell by 10.97% to $60.3 million in 2022, then crashed by 37.48% to $37.7 million in 2023, then grew by 12.37% to $42.4 million in 2024, then dropped by 5.17% to $40.2 million in 2025.
- Business Quant data shows Total Liabilities for BNR at $40.2 million in Q4 2025, $36.9 million in Q3 2025, and $36.4 million in Q2 2025.